Indeed, prominent RLT drug targets likePSMA, somatostatin receptor type 2, fibroblast activated protein alpha(FAPα), carbonic anhydrase 9, and the bombesin receptor areall highly overexpressed on cancer cells (>105 receptorsper cell). The gene discussed is FAP; the disease is cancer.